Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model von Nguyen, H G, Yang, J C, Kung, H-J, Shi, X-B, Tilki, D, Lara, P N, DeVere White, R W, Gao, A C, Evans, C P

Volltext

miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT von Kao, C-J, Martiniez, A, Shi, X-B, Yang, J, Evans, C P, Dobi, A, deVere White, R W, Kung, H-J

Volltext

The androgen receptor is a negative regulator of eIF4E phosphorylation at S209: implications for the use of mTOR inhibitors in advanced prostate cancer von D'Abronzo, L S, Bose, S, Crapuchettes, M E, Beggs, R E, Vinall, R L, Tepper, C G, Siddiqui, S, Mudryj, M, Melgoza, F U, Durbin-Johnson, B P, deVere White, R W, Ghosh, P M

Volltext

A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells von Wang, Y, Kreisberg, J I, Bedolla, R G, Mikhailova, M, deVere White, R W, Ghosh, P M

Volltext

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival von Wang, Y, Mikhailova, M, Bose, S, Pan, C-X, White, R W deVere, Ghosh, P M

Volltext

Tumor suppressive miR-124 targets androgen receptor and inhibits proliferation of prostate cancer cells von Shi, X-B, Xue, L, Ma, A-H, Tepper, C G, Gandour-Edwards, R, Kung, H-J, deVere White, R W

Volltext

Inappropriate activation of androgen receptor by relaxin via β-catenin pathway von Liu, S, Vinall, R L, Tepper, C, Shi, X-B, Xue, L R, Ma, A-H, Wang, L-Y, Fitzgerald, L D, Wu, Z, Gandour-Edwards, R, deVere White, R W, Kung, H-J

Volltext

The Effect of Sirolimus on Prostate‐Specific Antigen (PSA) Levels in Male Renal Transplant Recipients Without Prostate Cancer von Chamie, K., Ghosh, P. M., Koppie, T. M., Romero, V., Troppmann, C., DeVere White, R. W.

Volltext

p53 in Prostate Cancer: Frequent Expressed Transition Mutations von Chi, Sung-Gil, deVere White, Ralph W., Meyers, Frederick J., Siders, Douglas B., Lee, Fred, Gumerlock, Paul H.

Volltext

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors von Meyers, Frederick J., Gumerlock, Paul H., Chi, Sung Gil, Borchers, Holger, Deitch, Arline D., White, Ralph W. deVere

Volltext

Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions von Dow, James K, deVere White, Ralph W

Volltext

Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples von Spindler, J., Wiegand, A., Bagni, R. K., Lee, K., Kearney, M. F., Maldarelli, F., Pinto, Peter A., Linehan, W. Marston, Vocke, C. D., Delviks-Frankenberry, K. A., deVere White, R. W., Del Prete, G. Q., Mellors, John W., Lifson, J. D., KewalRamani, V. N., Pathak, V. K., Coffin, J. M., Le Grice, Stuart F. J.

Volltext

Abnormalities of apoptotic and cell cycle regulatory proteins in distinct histopathologic components of benign prostatic hyperplasia von Gandour-Edwards, R, Mack, P C, deVere-White, R W, Gumerlock, P H

Volltext

Acute toxicity of three-dimensional conformal radiotherapy in prostate cancer patients eligible for implant monotherapy von Chou, Rachel H, Wilder, Richard B, Ji, Ming, Ryu, Janice K, Leigh, Bryan R, Earle, John D, Doggett, R.L.Scotte, Kubo, H.Dale, Roach, Mack, deVere White, Ralph W

Volltext

Inhibition of Akt pathways in the treatment of prostate cancer von Nelson, E C, Evans, C P, Mack, P C, Devere-White, R W, Lara, P N

Volltext

Inappropriate activation of androgen receptor by relaxin via [beta]-catenin pathway von Liu, S, Vinall, R L, Tepper, C, Shi, X-B, Xue, L R, Ma, A-H, Wang, L-Y

Volltext

BCL2 antisense transcripts decrease intracellular Bcl2 expression and sensitize LNCaP prostate cancer cells to apoptosis-inducing agents von SHI, Xu-Bao, GUMERLOCK, Paul H, MUENZER, Jared T, WHITE, Ralph W

Volltext

Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation von Edelman, Martin J, Meyers, Frederick J, Miller, Tim R, Williams, Stephen G, Gandour-Edwards, Regina, deVere White, Ralph W

Volltext

Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP Cells von Tan, Jiann-an, Sharief, Yousuf, Hamil, Katherine G, Gregory, Christopher W, Zang, De-Ying, Sar, Madhabananda, Gumerlock, Paul H, deVere White, Ralph W, Pretlow, Thomas G, Harris, Stephen E, Wilson, Elizabeth M, Mohler, James L, French, Frank S

Volltext

Frequent alteration of CDKN2 (p16(INK4A)/MTS1) expression in human primary prostate carcinomas von Chi, S G, deVere White, R W, Muenzer, J T, Gumerlock, P H

Volltext